Health
Study: Anti-microRNA drug significantly reduces miR-92a levels in human peripheral blood – News-Medical.Net
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
Inhibition of miR-92a has shown beneficial effects in animal models, including improved vascularization after myocardial infarction, and accelerated wound healing, according to the peer-reviewed journal Nucleic Acid Therapeutics.
“Based on documented, promising therapeutic potential, locked nucleic acid (LNA)-based anti-miR-92a was further developed and tested in a …
-
General14 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business22 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business21 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General21 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips